Milwaukee Brewers slugger Ryan Braun has initiated a change to Major League Baseball's drug testing program.
Last spring, Braun successfully appealed a 50-game suspension stemming from a failed drug test in Oct. 2011. The perennial All-Star failed the test after an analysis concluded that his testerone levels were "insanely high."
Braun challenged the results saying that his urine sample was mishandled, and subsequently compromised once it left Milwaukee's clubhouse. It reportedly sat in the home of one of a drug collector for two days before being shipped to the World Anti-Doping Laboratory in Montreal for testing.
In an effort to avoid such a situation from happening again, MLB has opted to change the instrument used to collect urine samples.
According to two major league sources, MLB quietly switched from plastic to glass containers for urine samples in 2012, a direct result of Braun’s victory on grounds that the collection process was flawed. Before the Braun case, players gave the urine sample in a triple-sealed plastic container.
Now, the collectors use glass bottles, made by the same manufacturer, but considered even more secure. The bottles have a locking mechanism on the top, as opposed to tamper-proof stickers on the plastic version. The only way to open the glass bottles is to smash the top with a hammer, which the lab does in what a person familiar with the process described as a “controlled manner.”The new glass containers will make it even more difficult to tamper with a sample. The unannounced change was one of several updates to MLB's drug testing program in the past year.
Braun continues to be scrutinized for his alleged connection to performance-enhancing drug use. He, along with several other MLB players, are currently involved in an investigation surrounding the Miami-based Biogenesis clinc, which is accused of providing players with banned substances.
Via New York Daily News